Immunogenicity and safety of quadrivalent and 9-valent human papillomavirus vaccines in Indian clinical trial participants. [PDF]
Hum Vaccin Immunother, 2022 Garland SM +10 more
europepmc +1 more source
Intralesional bivalent and quadrivalent human papillomavirus vaccines didn't significantly enhance the response of multiple anogenital warts when co-administered with intralesional Candida antigen immunotherapy. A randomized controlled trial. [PDF]
Arch Dermatol Res, 2023 Fawzy M, Nofal E, Abdelkhalek N, Ehab R.
europepmc +1 more source
Efficacy and Safety of Messenger RNA Vaccines
Health Science Reports, Volume 9, Issue 6, June 2026.ABSTRACT Background and Aims The rapid development of mRNA vaccines has revolutionized infectious disease prevention and cancer immunotherapy. While their efficacy is well established, concerns about safety and immunopathological risks persist. This study aims to evaluate the immunogenicity, safety profiles, and design considerations of mRNA vaccines ...
Kesaobaka Batisani, David Chisompola
wiley +1 more source
Ethical Challenges to Improving Access to Human Papillomavirus Vaccines in Low- and Middle-Income Countries. [PDF]
NEJM Evid, 2022 Eke AC, Kerry VB.
europepmc +1 more source
On Imported and Domestic Human Papillomavirus Vaccines: Cognition, Attitude, and Willingness to Pay in Chinese Medical Students. [PDF]
Front Public Health, 2022 Zhou L +7 more
europepmc +1 more source
Perceptions of Cancer Risks Among Indigenous Women in Bolivia: A Qualitative Study
Health Science Reports, Volume 9, Issue 6, June 2026.ABSTRACT Background and Aims Cancer is responsible for nearly 20% of all deaths in Bolivia. This study explored sociocultural factors, risk perceptions, and healthcare‐seeking behaviors associated with cancer among Aymara women in a high‐altitude community in rural Bolivia.
Eda G. Christensen +6 more
wiley +1 more source
Trends in the Utilization of Human Papillomavirus Vaccines and the Incidence of Malignant Cervical Cancer in Women and Teenagers: A Secondary Analysis. [PDF]
Healthcare (Basel), 2022 Luna M, Upadhyay S.
europepmc +1 more source
International Journal of Cancer, Volume 158, Issue 11, Page 2983-2994, 1 June 2026.What's new? Anal and vulvar high‐grade squamous intraepithelial lesions (HSILs) frequently recur following treatment. Additional genital and anal procedures, however, can be distressing for patients and are potentially disfiguring. This trial assessed whether the 9‐valent human papillomavirus (9vHPV) vaccine reduces HSIL recurrence risk or HPV ...
Helen C. Stankiewicz Karita +13 more
wiley +1 more source
Human papillomavirus \u2013 2019
This online series of 15 webinars provides an overview of the principles of vaccination, general recommendations, immunization strategies for providers, and specific information about vaccine-preventable diseases and the vaccines that prevent them.
core
Review of Human Papillomavirus Vaccination Programs in United States Schools
Background: School vaccination programs (school-based and school-located) that include the human papillomavirus (HPV) vaccine have been implemented throughout the United States since 2009. Methods: We conducted a review of school HPV vaccination programs
Misra, Sanghamitra M +9 more
core +1 more source